Jagiellonian University at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Jagiellonian University brings 3 presentations to ESGCT 2026 in Hamburg. Its work centres on the heart and muscle in Duchenne muscular dystrophy, from editing patient-derived heart cells to muscle-targeted AAV that raises cystathionine gamma-lyase in a mouse model. A second strand compares cell types for stem cell treatment of heart failure.
| Organization | ESGCT 2026 Attendance |
|---|---|
Jagiellonian University Kraków, Poland | |
Poster Wed Oct 28 1:30pm–3:30pm Gene editing reveals unexpected partial dystrophin preservation and electromechanical defects in hiPSC-derived cardiomyocytes from a Duchenne muscular dystrophy patient Poster Thu Oct 29 2:00pm–4:00pm Genetic augmentation of human induced pluripotent stem cell-based therapies for heart failure: comparison of cardiomyocytes and cardiac progenitor cells in a murine model Poster Thu Oct 29 2:00pm–4:00pm Muscle-targeted AAVMYO2-mediated overexpression of cystathionine gamma-lyase in the mdx mouse model of Duchenne muscular dystrophy |
Instantly find 20 buyers from Jagiellonian University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction